Drug Profile
Citreamicin alpha
Alternative Names: LL E 19085alphaLatest Information Update: 29 Sep 2011
Price :
$50
*
At a glance
- Originator Wyeth
- Class Antibacterials
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 18 Oct 1996 No-Development-Reported for Bacterial infections in USA (Unknown route)